Home > Healthcare > Medical Devices > Surgical Devices > Embolic Protection Devices Market

Embolic Protection Devices Market Size

  • Report ID: GMI2417
  • Published Date: Jul 2023
  • Report Format: PDF

Embolic Protection Devices Market Size

Embolic Protection Devices Market was worth USD 1.4 billion in 2022. Driven by the increasing number of cardiovascular diseases (CVDs) globally, the industry is estimated to witness over 8.5% CAGR between 2023 and 2032. According to the WHO, CVDs are the leading cause of death globally, accounting for 17.9 million deaths in 2022.

 

The growing number of patients suffering from cardiac problems is fueling the need for percutaneous coronary interventions and the subsequent rise in demand for interventional cardiology & peripheral vascular devices. As per CDC, coronary artery disease is the most prevalent kind of heart disease in the U.S. The growing prevalence of CAD is contributing to rising product demand. Additionally, embolic protection devices provide the most effective, evidence-based method for decreasing significant adverse cardiovascular events and periprocedural myocardial infarction during SVG procedures, which will favor their adoption through 2032.

 

Embolic Protection Devices Market Growth Drivers & Restraints

The market is poised to gain significant momentum attributed to the favorable reimbursement scenario across American nations and the introduction of new advanced embolic protection devices. However, the availability of cheaper alternatives to embolic protection devices may lead to sluggish growth. Besides, the high cost of these devices may adversely impact product adoption rate since healthcare professionals in developing nations prefer inexpensive medical equipment.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Embolic protection devices market was valued at USD 1.4 billion in 2022 and is poised to exhibit over 8.5% CAGR from 2023 to 2032 owing to the rising prevalence of cardiovascular diseases (CVDs) globally.

The embolic protection devices market from the distal filters segment is estimated to grow at above 8.5% CAGR over 2023-2032 and is expected to generate USD 1.9 billion by 2032 driven by the availability of a wide range of specifications and the surging usage of distal filters.

North America amassed over 35.5% share of the embolic protection devices market in 2022 and is foreseen to be valued at USD 1 billion by 2032 attributed to the rising prevalence of cardiovascular and neurovascular diseases in the region.

Some of the top players engaged in the industry are Transverse Medical, Inc., Abbott Laboratories, Cardinal Health, Allium Medica, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Contego Medical, LLC, Keystone Heart, Medtronic, Metactive Medical, Boston Scientific Corporation, and Innovative Cardiovascular Solutions, LLC.

Embolic Protection Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 349
  • Countries covered: 30
  • Pages: 210
 Download Free Sample